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We propose a new parametric time-varying shared frailty model
to represent changes over time in population heterogeneity, for use
with bivariate current status data. The model uses a power transfor-
mation of a time-invariant frailty U , and is particularly convenient
when U is a member of the generalized gamma family. This model
avoids some shortcomings of a previously suggested time-varying
frailty model, notably time-dependent support. We describe some key
properties of the model, including its relative frailty variance func-
tion in different settings and how the model can be fitted to data. We
describe several applications to shared frailty modeling of bivariate
current status data on infectious diseases, in which the frailty repre-
sents age-dependent heterogeneity in contact rates or susceptibility
to infection.
1. Introduction. A standard way of representing individual heterogene-
ity in the hazard rate of an event of interest is through the multiplicative
frailty model
λ(t,U) = Uλ0(t),
where U is a positive random variable, the frailty, λ(t,U) is the hazard at
time t of an individual with frailty U , and λ0(t) is a baseline hazard common
to all individuals in the population [Aalen, Borgan and Gjessing (2008),
Duchateau and Janssen (2008), Wienke (2011)]. The degree of heterogeneity
of the population is then characterized by the variance of U .
In certain circumstances, one may be interested in how the heterogeneity
of the population might vary over time as a result of changes in individuals’
frailties. Such variation might occur in medical applications, for example,
Received January 2013; revised September 2013.
1Supported by funding from the Medical Research Council and a Royal Society Wolfson
Research Merit Award to C. P. Farrington.
Key words and phrases. Current status data, frailty, gamma, generalized gamma, het-
erogeneity, infectious disease, shared frailty model, time-varying frailty.
This is an electronic reprint of the original article published by the
Institute of Mathematical Statistics in The Annals of Applied Statistics,
2014, Vol. 8, No. 1, 430–447. This reprint differs from the original in pagination
and typographic detail.
1
2 D. G. ENKI, A. NOUFAILY AND C. P. FARRINGTON
resulting from changes in individuals’ health or behavior. The motivation
for this work, revisited later in the paper, stems from the need to incorpo-
rate unmeasured heterogeneity in contact rates between individuals when
estimating hazards of infection from samples of serological data. Such het-
erogeneities are likely to evolve with age, owing to changes in behavior.
In a single sample of data, it is not possible mathematically to disen-
tangle the baseline survivor function from the frailty distribution. For this
reason, we specifically restrict attention to shared frailty models, in which
this particular identifiability problem does not occur. This setting is very
natural for our intended application to serological survey data, which arise
very commonly in practice and are often the main primary source of data
for infectious disease modeling. Since serum samples taken from a collection
of individuals are usually tested for several different infections, the data are
typically multivariate and a shared frailty framework arises very naturally.
New identifiability issues ensue, however, which will be discussed later in
the paper.
For simplicity of presentation, the model and its properties are described
first in a univariate context. Incorporating time variation in the population
heterogeneity suggests the more general frailty model
λ(t,U) = U(t)λ0(t),
where U(t) is a positive random variable of mean 1 describing how an in-
dividual’s frailty evolves over time. To clarify the issues, suppose that the
event of interest is nonterminal. At time t, the population includes people
who have experienced the event and people who have not had the event
(the survivors). The unconditional variance of U(t) at time t, var{U(t)},
describes the heterogeneity of the frailty U(t) at time t in the entire pop-
ulation. The unconditional heterogeneity is distinct from the heterogeneity
of U(t) in the population of survivors, described by the conditional variance
var{U(t)|T > t}.
The relative change over time in the heterogeneity of the survivor popu-
lation involves both the change in the frailty variance and also the selection
effect of survival to time t. This is quantified by the relative frailty variance
[Farrington, Unkel and Anaya-Izquierdo (2012)],
RFV∗(t) =
var{U(t)|T > t}
[E{U(t)|T > t}]2
.
In a shared frailty model, an empirical estimate of RFV∗(t) or a related
quantity may be obtained, which can guide the choice of U(t) [Farrington et
al. (2013), Unkel and Farrington (2012)]. A natural and flexible framework
for representing time-varying frailties is to take U(t) to be a dynamically
evolving stochastic process, such as a multiplicative Wiener process or a
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Levy process [Aalen, Borgan and Gjessing (2008)]. However, the undoubted
attractiveness of this framework is tempered by the complexity of the models
involved and, more prosaically, by inherent problems of identifiability when
only a single observation is available on each individual, as is often the case
in applications.
These considerations led to the development of a simpler class of time-
varying frailty models of the form
U(t) =w(t,U1, . . . ,Uk),
where w(·) is a deterministic function of unit mean and U1, . . . ,Uk are inde-
pendent time-invariant frailties. In these models, the time-invariant frailties
are modulated over time, the modulation occurring in the same way for all
individuals in the population. This model will be appropriate when the evo-
lution of individual frailties is to some extent governed by common factors,
or at least when interest resides in such an average trajectory. This class of
models includes, for example, piecewise constant frailty models [Paik, Tsai
and Ottman (1994)], for which
w(t,U1, . . . ,Uk) =
k∑
i=1
UiIAi(t) =
k∏
i=1
U
IAi(t)
i ,
where IA(t) is 1 if t ∈A and 0 otherwise, and the Ai partition the positive
half-line. Further simplification comes from restricting these models to the
additive or multiplicative forms
w(t,U1, . . . ,Uk) =
k∑
i=1
piw(t,Ui),
w(t,U1, . . . ,Uk) =
k∏
i=1
w(t,Ui),
where the w(t,Ui) have unit mean and p1+ · · ·+pk = 1. In particular, models
with
w(t,U) = 1+ (U − 1)h(t),
where 0≤ h(t) ≤ 1 were introduced in Farrington et al. (2013). A detailed
discussion of their application to infectious disease data may be found in
Unkel et al. (2014).
A shortcoming of this model is that the range of U(t) is time-dependent,
namely,
1− h(t)<U(t)<∞,
this restriction being required to maintain U(t) > 0. Restricting the range
in this way is artificial and unsatisfactory. Note also that there is no obvious
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family of distributions of U on (0,∞) which is closed under the transforma-
tion 1 + (U − 1)h(t) (for given t).
In this paper, we propose a new family of time-varying frailty models
which overcomes these shortcomings. In the next section we introduce the
new model. In Section 3 we study the unconditional variance of U(t) and its
relative frailty variance function, and discuss identifiability issues arising in
this type of model. In Section 4 we describe how to fit a shared frailty model
with this time-varying frailty U(t) to current status data. The performance
of the methods are studied by simulation in Section 5. Then in Section 6 we
apply these methods to two serological survey data sets.
2. A new family of time-varying frailty models. Our proposal is to re-
place the linear (in U ) transformation w(t,U) = 1+ (U − 1)h(t) by a power
transformation, in which
w(t,U) = Uh(t) = eh(t) log(U),
where U > 0, h(t) > 0 and h(0) = 1. Note that the range of U(t) = w(t,U)
is (0,∞) whatever the choice of h(t). Furthermore, if U belongs to the gen-
eralized gamma family with parameters θ, k, β > 0 and density
f(u) =
β
θkβΓ(k)
ukβ−1e−(u/θ)
β
, u > 0,
where Γ(k) is the gamma function, then U(t) is a generalized gamma with
parameters θt, k, βt > 0 and density
ft(u) =
βt
θt
kβtΓ(k)
ukβt−1e−(u/θt)
βt
, u > 0,
where θt = θ
h(t) and βt = β/h(t). Note that θ0 = θ and β0 = β. This is the pa-
rameterization of the generalized gamma used by Noufaily and Jones (2013).
The generalized gamma family includes the gamma (for β = 1), theWeibull
(for k = 1) and, as a limiting case for k→∞, the lognormal densities. The
generalized gamma distribution has been used as a frailty density by Bal-
akrishnan and Peng (2006). The function h(t) can be used to denote a
smooth transition from one member of the family to another: for example,
h(t) = e−ρt + (1− e−ρt)β, with ρ > 0, denotes a transition toward a gamma
density as t→∞. Further properties of the family are described in Cox et
al. (2007).
More general models may then be built up multiplicatively from such
building blocks, with
U(t) =w(t,U1, . . . ,Uk) =
k∏
i=1
U
hi(t)
i = exp{h1(t) log(U1)+ · · ·+hk(t) log(Uk)}.
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Thus,
log{U(t)}=
k∑
i=1
hi(t) log(Ui).
In general, such models do not belong to the generalized gamma family,
with one exception: if the Ui(t) are lognormal, then so is U(t). Note that
models involving several function hi(t) may present identifiability problems
and should be used sparingly. An application-driven example is given in
Section 6.2.
3. Representing time-varying heterogeneity. The frailty U(t) is used to
represent individual heterogeneity in factors impinging upon the event haz-
ard at time t, the degree of heterogeneity being quantified by its variance.
Both unconditional and conditional variances are of interest, with different
interpretations.
3.1. Unconditional variance. The moments of U(t) = Uh(t) are
E{U(t)r}= θt
rΓ(k+ r/βt)
Γ(k)
.
The squared coefficient of variation of U(t) is
CV{U(t)}=
Γ(k+2/βt)Γ(k)
Γ(k+1/βt)
2 − 1.
The derivative of CV{U(t)} with respect to t is
CV′{U(t)}=
2
β0
h′(t){1 +CV{U(t)}}{ψ(k +2/βt)− ψ(k+ 1/βt)},
where ψ(x) is the digamma function. Since ψ(x) is increasing on R+, h(t)
and CV{U(t)} have the same turning points; if h(t) is monotone decreasing
to zero, then so is CV{U(t)}.
When the event of interest is not terminal, and mortality can be ignored,
the squared coefficient of variation CV{U(t)} describes the degree of hetero-
geneity in the population at time t. The variation in heterogeneity is thus
described in qualitative terms by the function h(t).
In applications, it is convenient to ensure that U(t) has unit mean, which
makes it easier to specify a model for the baseline hazard. Accordingly, we
shall normalize U(t) so that it has unit mean, by dividing Uh(t) by its mean
and redefining U(t) as follows:
U(t) =
Γ(k)
θtΓ(k+1/βt)
Uh(t).
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The (squared) coefficient of variation is unaffected by this normalization. It
may also be desirable to set E(U) = 1. This is readily achieved by setting
θ =
Γ(k)
Γ(k+1/β)
,
thus reducing the number of parameters to be estimated.
3.2. Relative frailty variance: Time invariant case. When h(t) = 1 and
the event is not terminal, the heterogeneity in the population does not vary
with t, unless U is also associated with mortality in the population. However,
the heterogeneity within the subpopulation who have not experienced the
event (the event survivors) will vary, owing to selection effects. This is de-
scribed by the relative frailty variance, or the conditional squared coefficient
of variation
RFV∗(t) =
var{U |T > t}
{E(U |T > t)}2
.
This can be scaled so that it does not depend on the baseline hazard;
this scaled version is denoted RFV(s). In shared frailty models, RFV(s) is
closely related to the cross-ratio function [Oakes (1989)], which can be used
to guide the choice of U .
The generalized gamma is a special case of the extended generalized
gamma and inverse Gaussian (Egg) family of distributions, discussed in Far-
rington, Unkel and Anaya-Izquierdo (2012). Specifically, the Egg family of
densities is
f(u;α,β, θ, λ) =
1
I∗(α,β, θ, λ)
(
u
θ
)α−1
e−λ(u/θ)e−(u/θ)
β
, u > 0,
where α,β, θ, λ > 0 and
I∗(α,β, θ, λ) =
∫
∞
0
(
u
θ
)α−1
e−λ(u/θ)e−(u/θ)
β
du.
Hence, the generalized gamma is a member of the Egg family with λ = 0
and α= kβ. Its scaled relative frailty variance function is therefore
RFV(s) =
I∗(kβ +2, β,1, sθ)I∗(kβ,β,1, sθ)
I∗(kβ + 1, β,1, sθ)2
− 1.
This tends to the limit (kβ)−1 as s→∞. It is monotone decreasing for
0 < β < 1, monotone increasing for β > 1, and constant when β = 1 (in
which case the density reduces to the gamma).
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3.3. Relative frailty variance: Time-varying case. When h(t) is not iden-
tically 1, the heterogeneity in event survivors can also be summarized by the
relative frailty variance RFV∗(t), now defined as
RFV∗(t) =
var{U(t)|T > t}
[E{U(t)|T > t}]2
.
However, because there are two time scales involved, namely, that at which
events arise and that at which h(t) changes, this can no longer be re-
expressed in a way that does not depend on the baseline hazard.
For arbitrary U and h(t), no explicit expressions for RFV∗(t) are available.
Let
Ij(t) =
∫
∞
0
U(t)j exp
{
−
∫ t
0
U(s)λ0(s)ds
}
f(u)du,
where f is the density of u. Then the relative frailty variance is
RFV∗(t) =
I2(t)I1(t)
I1(t)2
− 1.
This can be evaluated numerically. Figure 1 shows several plots of RFV∗(t)
for U(t) = Uh(t)/E{Uh(t)} with E(U) = 1, for different values of k and β
and contrasting choices of h(t) and baseline hazard. The baseline hazards
are all chosen to have roughly the same integrated hazard over the range of
t displayed. The plots show that RFV∗(t) is not greatly influenced by the
baseline hazard, which depends primarily on h(t) and the parameters k and
β. RFV∗(t) can be estimated empirically in shared frailty models, and so
can be used for inference about U(t).
3.4. Identifiability issues. In a shared time-invariant frailty model, it is
possible to separate the baseline hazard functions from the frailty. The func-
tion RFV(s) is then equivalent to the cross-ratio function [Oakes (1989)].
With bivariate right-censored data, a plot of RFV(s) can thus be obtained
directly. For current status data, the related association measure φ, which
tracks the cross-ratio function, can be obtained [Unkel and Farrington (2012)].
Briefly, φ is derived at each sampling time t from the association parameter
for the Clayton copula relating the empirical marginal and joint survivor
functions at time t.
When a time-varying frailty U(t) is introduced, it remains possible to
separate the baseline hazard from the frailty, as above, using RFV∗(t) or
the related measure φ. However, it is not possible to distinguish between
time-variation in U(t) from selection effects reflecting the choice of frailty
distributions, and the direct connection with the cross-ratio function is lost.
To clarify the issue, suppose that the variance of U is small, then U(t)
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Fig. 1. Relative frailty variance function RFV∗(t) for time-varying generalized gamma
frailty Uh(t) with E(U) = 1 and h(t) = exp(−ρt2). Parameter values are k = 0.5 and, top
to bottom in each panel, β = 0.8,1,1.25. Left panels: h(t) decreasing (ρ = 0.0001). Right
panels: h(t) increasing (ρ = −0.0001). Top panels: hazard constant, λ(t) = e−3.34. Mid-
dle panels: hazard increasing, λ(t) = exp(−4.5+ t/25). Bottom panels: hazard decreasing,
λ(t) = exp(−2.5− t/25).
[not normalized, but parameterized so that E(U) = 1] can be approximated
linearly to the first order as
U(t)≃ 1 + (U − 1)h(t),
which thus approximates the time-varying frailty model described in Far-
rington, Unkel and Anaya-Izquierdo (2012). Let RFV∗(t) denote the relative
frailty variance of U(t) and RFV∗0(t) the relative frailty variance of U . Also,
let µc(t) = E[U |T > t] be the mean of U in survivors at time t. Direct cal-
culation then yields
RFV∗(t)≃RFV∗0(t)
[
h(t)
h(t) + µc(t)−1(1− h(t))
]2
.
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Note that this expression differs from equation (23) of Farrington, Unkel
and Anaya-Izquierdo (2012), which contains an error. As noted there, the
variation has two components: a selection effect stemming from RFV∗0(t) and
a component governed largely, but not exclusively, by h(t). For example, if
h(t) tends to zero, so will this term.
Thus, if RFV∗(t) is observed to change over time, it is not usually possible
to identify whether this is due to changing heterogeneity, as represented
by a nonconstant h(t), or a selection effect, represented by a nonconstant
RFV∗0(t), or both, without recourse to external information: the two effects
are confounded. This is unfortunate because distinguishing between selection
effects and evolving heterogeneity can be important in some applications.
Nevertheless, it is possible, and useful, to fit and contrast the two models
corresponding to the most extreme scenarios: gamma U [which has con-
stant RFV∗0(t)] with time-varying h(t), on the one hand, and nongamma U
[which has nonconstant RFV∗0(t)] with no time variation, namely, h(t) = 1.
For the first option, the shape of the association plot (whether the empir-
ical cross-ratio function or the empirical plot of φ) can be used to suggest
suitable parameterizations of h(t). In practical applications, including those
described below, it is often found that the selection effects of available para-
metric frailty models cannot alone reproduce the observed patterns. In some
circumstances, this is due to theoretical restrictions on the shapes of RFV(s)
[Farrington, Unkel and Anaya-Izquierdo (2012)]. More generally, this sug-
gests either that the available models for time-invariant frailties are insuffi-
ciently flexible or that time-variation in heterogeneity is the more plausible
explanation.
4. Fitting the model to data. Throughout, we shall use
U(t) =
Uh(t)
E{Uh(t)}
,
so that E{U(t)}= 1. Furthermore, we shall take E(U) = 1, so that the den-
sity of U involves just the two parameters k and β. Write µ(t) =E{Uh(t)}.
4.1. Evaluating the survivor function. Fitting the model to data requires
the population survivor function (i.e., the probability of remaining event-
free) to be evaluated. This is
S(t) =E{S(t|U = u)}=
∫
∞
0
exp
(
−
∫ t
0
uh(s)
λ0(s)
µ(s)
ds
)
f(u)du.
In order to avoid evaluating the double integral, an approximate approach
is used. Suppose that time is measured in discrete units of length δ, in such
a way that every time point at which an observation is made is a multiple
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of δ. The functions λ0(t) and h(t), and hence µ(t), may be approximated by
step functions with steps at the points mδ, m= 1,2, . . . , taking the values
λ(mδ), h(mδ) and µ(mδ), respectively, on the interval ((m−1)δ,mδ]. Then,
for t= jδ,
∫ t
0
uh(s)
λ0(s)
µ(s)
ds≃ δ
j∑
i=1
uh(iδ)
λ0(iδ)
µ(iδ)
.
The remaining outer integral over u can then be evaluated numerically;
we have used the integrate function in R, version 2.14.0 [R Development
Core Team (2012)]. Convergence problems may arise when h(t) is increasing;
accordingly, we constrained h(t) to be decreasing (or unity) as required in
our applications.
In the next section, we will consider a two-component frailty model of the
form
U(t) = Uh(t)V,
where V is gamma with mean 1 and variance 1/k2, and density g(v). Thus,
S(t) =
∫
∞
0
∫
∞
0
{
exp
(
−
∫ t
0
uh(s)v
λ0(s)
µ(s)
ds
)}
f(u)g(v)dudv
=
∫
∞
0
[∫
∞
0
{
exp
(
−v
∫ t
0
uh(s)
λ0(s)
µ(s)
ds
)}
g(v)dv
]
f(u)du.
For t= jδ, consider the expression in the square bracket and write
I(t, u) =
∫ t
0
uh(s)
λ0(s)
µ(s)
ds
≃ δ
j∑
i=1
uh(jδ)
λ0(jδ)
µ(jδ)
.
Then, using the Laplace transform for a gamma random variable, we obtain
∫
∞
0
e−vI(t,u)g(v)dv =
[
k2
k2 + I(t, u)
]k2
and, hence,
S(t) =
∫
∞
0
[
k2
k2 + I(t, u)
]k2
f(u)du.
This last expression can be integrated numerically.
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4.2. Shared frailty model for current status data. The parameters of the
frailty distribution(s) and the function h(t) are readily estimated from a
shared frailty model for multivariate survival data [Aalen, Borgan and Gjess-
ing (2008), Duchateau and Janssen (2008), Wienke (2011)]. We restrict at-
tention to the bivariate frailty model linking two hazard functions with a
common frailty:
λ1(t|U,V, . . .) =U(t)λ01(t), λ2(t|U,V, . . .) = U(t)λ02(t).
We consider estimation based on bivariate current status data, commonly
available from serological surveys of infectious diseases. At time t we have
a 4-tuple nijt (i, j = 0,1), where n00t denotes the number of individuals
experiencing neither event by age t, n10t the number of individuals experi-
encing event 1 but not event 2 by time t, and so on. Let Sij(t) denote the
corresponding probabilities, for example, S00(t) is the probability that an
individual of age t has not experienced either event by time t. Then
S00(t) = E
{
exp
(
−
∫ t
0
U(s)[λ01(s) + λ02(s)] ds
)}
,
S01(t) = E
{
exp
(
−
∫ t
0
U(s)λ01(s)ds
)}
− S00(t),
S10(t) = E
{
exp
(
−
∫ t
0
U(s)λ02(s)ds
)}
− S00(t),
S11(t) = 1− S00(t)− S01(t)− S10(t).
These probabilities are evaluated by discretizing the functions h(t), λ01(t)
and λ02(t) as described above. Let γ denote the vector of parameters de-
scribing f(u), h(t), λ01(t) and λ02(t). The multinomial log-likelihood kernel
is then
Loglik(γ) =
∑
t
1∑
i,j=0
nijt log(Sij(t)).
This was optimized using function nlm in R, version 2.14.0 [R Develop-
ment Core Team (2012)]. Approximate confidence intervals were obtained
using the profile likelihood method. Goodness of fit was assessed using the
deviance, and models were compared using the AIC.
5. Simulations. We checked the performance of the procedures suggested
for current status data in a small simulation study. The parameter choices
for the simulations broadly reflect the patterns observed in the data to be
analyzed in the next section, namely, declining relative frailty variances.
We assumed constant baseline hazards λ01(t) = λ02(t) = 0.05, and ob-
tained the survivor functions Sij(t), i, j = 0,1, for two scenarios: (a) U
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Table 1
Simulation results for gamma frailty with declining heterogeneity
Bias(ρˆ) RMSE(ρˆ) Bias(kˆ) RMSE(kˆ)
n= 200
k = 1 ρ= 0.01 0.0007 0.0045 0.0311 0.2959
ρ= 0.002 0.0000 0.0003 0.0031 0.1045
k = 0.2 ρ= 0.01 0.0001 0.0011 0.0011 0.0228
ρ= 0.002 0.0000 0.0001 0.0004 0.0114
n= 50
k = 1 ρ= 0.01 0.0036 0.0143 0.0906 0.6470
ρ= 0.002 0.0000 0.0007 0.0178 0.2218
k = 0.2 ρ= 0.01 0.0004 0.0022 0.0004 0.0448
ρ= 0.002 0.0000 0.0002 0.0024 0.0229
gamma with mean 1 and variance k−1 with exponentially declining hetero-
geneity h(t) = exp(−ρt2), and (b) U generalized gamma with mean 1 and
parameters k,β, and constant heterogeneity (ρ = 0). For scenario (b), the
model was parameterized using β and α= kβ, to reduce correlations between
the parameter estimates. We generated 4-nomial samples of size n= 200 and
n= 50 at each year t= 1, . . . ,50. The procedure was run N = 400 times for
each parameter combination. The results for scenario (a) are shown in Ta-
ble 1, and those for scenario (b) in Table 2.
When n= 200, the estimated bias in ρ and k, and in β and γ, is small,
seldom exceeding 5% of the true parameter value. The estimated root mean
squared errors (RMSE) are larger, reflecting the lack of information available
from current status data. When n = 50, the biases and RMSE values are
greater, owing to the sparseness of the data at young ages and the consequent
Table 2
Simulation results for generalized gamma frailty with constant heterogeneity
Bias(βˆ) RMSE(βˆ) Bias(αˆ) RMSE(αˆ)
n= 200
k = 1 β = 0.7 0.0064 0.1983 0.0402 0.1524
β = 0.4 0.0214 0.1269 0.0291 0.1647
k = 0.2 β = 0.7 0.0310 0.2381 0.0042 0.0227
β = 0.4 0.0087 0.1199 0.0021 0.0129
n= 50
k = 1 β = 0.7 0.1887 0.9342 0.1456 0.5433
β = 0.4 0.1172 0.3673 0.0797 0.4713
k = 0.2 β = 0.7 0.3541 1.1469 0.0116 0.0722
β = 0.4 0.0633 0.3813 0.0022 0.0196
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Table 3
Simulation results for misspecified gamma frailty
model
ρ Bias(ρˆ) RMSE(ρˆ)
0.01 0.0030 0.0044
0.002 0.0006 0.0006
0 0.0001 0.0001
lack of information on ρ and β. The RMSE values suggest that, in scenario
(a), larger values of ρ, corresponding to rapid drops in heterogeneity, are
more difficult to estimate, whereas in scenario (b), β becomes more difficult
to estimate as it approaches 1, that is, as the distribution of U becomes closer
to the gamma. In all cases, the baseline hazard parameters are estimated
with little bias (not shown).
We obtained asymptotic standard errors for the parameter estimates from
a numerical estimate of the Hessian matrix. The means of these standard
errors were generally less than the standard deviations of the simulated pa-
rameter estimates, and Wald confidence intervals had coverage probabilities
lower than the nominal values (results not shown). The discrepancy was most
marked for the parameters relating to the frailty (ρ, k, β, α). We conclude
that asymptotic standard errors may be unreliable in samples of moderate
size, and recommend that interval estimates be obtained by bootstrapping
or profile likelihood.
We also undertook a further simulation to investigate the robustness of
inferences about ρ to misspecification of the frailty distribution. Thus, we
generated data (400 replicates with n= 200 at each year) from a generalized
gamma frailty with β = 0.5 and k = 2, with U(t) of unit mean. We fitted the
same gamma model as for Table 1 to these simulated data. The results are
shown in Table 3. As expected, the bias for ρˆ is worse than in Table 1 (for
n= 200), though only marginally so, and the RMSE values are little affected.
We conclude that the methods are reasonably robust to mild misspecification
of the frailty within the generalized gamma family.
6. Applications. We illustrate the methods with applications to two con-
trasting data sets, each involving a pair of infections. The data are serologi-
cal survey data from the UK and are described in detail in Farrington et al.
(2013) and Unkel et al. (2014). Each individual of age t is tested by two
laboratory assays to determine whether he or she has been infected or not
at some time prior to t. The data are thus paired current status data and are
observed at calendar years of age t= 1,2, . . . ,M . Each paired sample con-
tributes a likelihood term as described in the previous subsection. In some
instances, only one of the test results is available. In this case, the likelihood
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Fig. 2. Seroprevalence of Parvovirus B19 (left panel) and Cytomegalovirus (right panel)
infections with age (years). The lines show the fitted values obtained from the model with
shared frailty U(t)∝Uh(t) with gamma U and exponentially declining h(t).
contributions are obtained from the corresponding marginal probabilities.
We fit different models for U(t) according to whether the two infections
share a mode of transmission.
6.1. Parvovirus B19 and Cytomegalovirus infections. Parvovirus B19 is
transmitted via droplets via the respiratory route, whereas Cytomegalovirus
is transmitted by oral ingestion of contaminated secretions. Thus, the route
of transmission is different for the two infections. In childhood, transmis-
sion via these two routes is likely to be confounded, owing to the close-
ness of contacts between young children. Heterogeneity of contacts in early
childhood—for example, owing to variation in nursery attendance—is likely,
therefore, to induce an association between the infections. This is unlikely
to persist into adulthood, since the infections are transmitted differently.
Figure 2 shows the observed proportions with a positive test result, or
seroprevalences, by age, and Figure 3 shows the association between the
two infections in each pair, with a LOESS curve to represent the trend.
The measure of association used here, denoted φ, is described in Unkel
and Farrington (2012). It tracks the relative frailty variance RFV∗(t) and
hence the cross-ratio function, neither of which can be obtained directly
from current status data.
The association plot suggests that there is a high degree of heterogeneity
at early ages, which declines rapidly with age. As expected, there is evidence
of heterogeneity at young ages, possibly due to heterogeneity of contacts. An
alternative explanation, at young ages, could be variation in development
of the immune system. The decline in heterogeneity may be related to the
homogenizing influence of school attendance and other learned behaviors.
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Fig. 3. Association between Parvovirus B19 and Cytomegalovirus by age (years). The
dots represent the empirical values of the association parameter φˆ (with area inversely
proportional to the empirical variance of φˆ). The full line is a LOESS curve. The curved
dashed line shows the fitted values obtained from the model with shared frailty U(t)∝ Uh(t)
with gamma U and exponentially declining h(t). The curved dotted line shows the fit-
ted values obtained from the model with time-invariant generalized gamma frailty U . The
horizontal dashed line represents no association.
The LOESS curve in Figure 3 suggests that the time-varying frailty model
U(t) ∝ Uh(t) with h(t) = exp(−ρt2) might be an appropriate choice; the
constant of proportionality is the normalizing factor to ensure that U(t) has
unit mean for all t. We chose U to be a unit mean gamma random variable
with variance k−1 (but also tried a generalized gamma). We also fitted the
selection model, according to which the decline in the strength of association
is due entirely to selection effects. In this model, U is represented by a unit
mean generalized gamma random variable with parameters k and β, but
there is no time-varying effect, so ρ= 0. In each case the baseline hazards
were modeled using piecewise constant functions.
The results are in Table 4. The best fit is achieved by the time-varying
frailty model with gamma U . Unsurprisingly, in view of the identifiability
Table 4
Fit to Parvovirus B19 and Cytomegalovirus infection data
Model −Loglik Deviance df p-value AIC
Gamma with trend 4352.07 231.76 206 0.105 8732.14
Gen. Gamma, no trend 4357.35 242.32 206 0.042 8742.70
Gamma, no trend 4359.04 245.70 207 0.034 8744.09
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Fig. 4. Seroprevalence of Helicobacter pylori (left panel) and Toxoplasma (right panel)
infections with age (years). The lines show the fitted values obtained from the model with
shared frailty U(t)∝Uh(t)V with gamma U and V and exponentially declining h(t).
issues discussed earlier, a generalized gamma U gave no improvement over
the gamma for this model, though this lack of improvement does suggest
that the model for h(t) is not grossly misspecified. The selection model
gave a moderately worse fit to the data. The fitted association curves φˆ for
the two models are shown in Figure 3, and show that the selection model
does not adequately represent the association. Also included in Table 4 is
a simple gamma shared frailty model, for which the fit is less good. The
results for this model (as in the next example) differ slightly from those of
Unkel et al. (2014), as different age groups were used. We conclude that
the best fitting model is the time-varying frailty model; the observed and
fitted seroprevalences are shown in Figure 2. The parameters of this fitted
frailty model, with 95% profile likelihood confidence intervals, are as follows:
k1 = 0.168 (0.0630,0.775), ρ= 0.134 (0.0272,0.645).
6.2. Helicobacter pylori and Toxoplasma infection. Helicobacter pylori
and Toxoplasma infection are both transmitted by the oral route via inges-
tion of contaminated matter. Because the infections share a common route
of transmission, we might expect that heterogeneities in adult behavior will
be reflected in a persistent association between the infections.
Figure 4 shows the marginal seroprevalences for the two pairs, and Fig-
ure 5 the association plots. As for Parvovirus B19 and Cytomegalovirus,
there is substantial heterogeneity at young ages, declining with increasing
age. However, the decline is now not to zero: as expected, there remains
a small but persistent association in adulthood. This is most likely due to
heterogeneity in contacts via the common transmission route, owing to dif-
ferences in eating habits, hygiene and environmental factors.
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Fig. 5. Association between Helicobacter pylori and Toxoplasma by age (years). The dots
represent the empirical values of the association parameter φˆ (with area inversely propor-
tional to the empirical variance of φˆ). The full line is a LOESS curve. The curved dashed
line shows the fitted values obtained from the model with shared frailty U(t)∝ Uh(t)V with
gamma U and V and exponentially declining h(t). The curved dotted line shows the fit-
ted values obtained from the model with time-invariant generalized gamma frailty U . The
horizontal dashed line represents no association.
We thus propose a time-varying model for the frailty U(t) involving two
components. The first component is the “childhood” component Uh(t) with
h(t) = exp(−ρt2), representing heterogeneities in childhood as before. The
second component V represents adult heterogeneity in behavior associated
with transmission by the common route. Thus, V might represent variation
in exposure to the ingestion of contaminated matter. We assume that U and
V are independent random variables, both of unit mean. The frailty model
is thus
U(t)∝ U exp(−ρt
2)V,
the constant of proportionality being the normalizing factor to ensure U(t)
has expectation 1. We assume that both U and V are gamma with variances
k−11 and k
−1
2 , respectively; we also allowed U to be generalized gamma. We
also fitted a selection model in which U(t) = U is generalized gamma with
parameters k1 and β, but with ρ= 0.
The results are in Table 5. As for the previous example, for the time-
varying frailty model, allowing a generalized gamma U gave virtually no
improvement over a gamma U . The time-varying frailty model gave only
a marginally better fit than the selection model with constant generalized
gamma frailty. However, the observed associations φ in Figure 5 are much
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Table 5
Fit to Helicobacter pylori and Toxoplasma infection data
Model −Loglik Deviance df p-value AIC
Gamma/Gamma with trend 4229.26 399.95 364 0.094 8496.52
Gen. Gamma, no trend 4230.86 403.15 365 0.082 8497.72
Gamma, no trend 4235.09 411.62 366 0.050 8504.18
more faithfully reproduced by the time-varying frailty model than by the se-
lection model. Both models fit better than the simple gamma shared frailty
model. We thus select the two-component time-varying frailty model as the
best one; its fit to the serological data in Figure 4 is good. The parame-
ters of this model, with 95% profile likelihood confidence intervals, are as
follows: k1 = 0.0572 (0.0215,0.275), k2 = 3.29 (1.87,9.98), and ρ = 0.0911
(0.0502,0.183).
7. Final remarks. We have presented a simple time-varying frailty model
in which time-invariant frailties are modulated over time by a deterministic
function. The major limitation of this kind of approach is that all individuals
are assumed to share the same trajectories over time. Thus, it is likely to be
applicable only when variation in heterogeneity is driven by a mechanism
common to all individuals, such as ageing.
The present model uses a power function of the (time-invariant) frailty,
rather than a linear function as previously suggested. Arguably, the new
model is more natural and avoids some limitations of the linear model, no-
tably time-dependent support. However, this benefit comes at the cost of
analytical tractability, which we overcame by a combination of discretiza-
tion and numerical integration. Nevertheless, the new model fits naturally
within a broad class of generalized gamma time-varying frailty models, from
which some analytical results may be exploited.
We focused attention on frailties within the generalized gamma family,
owing to its mathematical tractability and its appropriateness for our appli-
cation. This family is reasonably flexible in that it allows for both monotone
increasing and decreasing (and constant) relative frailty variance functions.
However, in some applications, other types of time trends might be required.
The new model does not provide any resolution of the central conun-
drum of time-varying frailty models, namely, how to distinguish between a
selection effect and genuine temporal variation in heterogeneity. However,
it provides some new tools to explore these contrasting interpretations in a
shared frailty context. The applications to serological survey data reinforce
the value of plotting the empirical and fitted values of the association mea-
sure φ. Such plots enable a more sensitive assessment of model fit than is
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possible by marginal observed and expected plots or single numerical sum-
maries of goodness of fit.
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